US Stock MarketDetailed Quotes

NBY NovaBay Pharmaceuticals

Watchlist

0.1400
+0.0002+0.14%

Close May 23 16:00 ET

0.1415
+0.0015+1.07%

Post 16:57 ET

5.30MMarket Cap-42P/E (TTM)

NovaBay Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-32.43%-1.57M

37.92%-4.13M

74.03%-314K

78.51%-363K

-33.43%-2.27M

42.29%-1.19M

27.61%-6.65M

72.00%-1.21M

-15.05%-1.69M

14.49%-1.7M

Net income from continuing operations

-129.74%-3.09M

9.13%-9.64M

49.94%-4.11M

-1,191.91%-1.76M

-12.76%-2.43M

-1,111.71%-1.35M

-82.14%-10.61M

-5,093.67%-8.21M

94.06%-136K

-15.92%-2.16M

Operating gains losses

--606K

94.27%-312K

94.26%-56K

88.19%-285K

----

-18.34%-5.45M

78.85%-976K

---2.41M

--0

Depreciation and amortization

-7.69%12K

-57.97%203K

-59.35%50K

-57.14%51K

-25.83%89K

-89.26%13K

305.88%483K

41.38%123K

891.67%119K

990.91%120K

Other non cash items

--783K

45.63%1.98M

269.01%578K

-50.73%947K

----

--1.36M

---342K

--1.92M

--0

Change In working capital

-18.57%57K

40.71%750K

-58.66%537K

163.68%619K

-361.54%-476K

191.67%70K

1,502.63%533K

1,723.75%1.3M

-267.30%-972K

140.81%182K

-Change in receivables

-121.60%-54K

498.03%1.21M

-1.88%157K

264.93%1.71M

-174.88%-900K

139.56%250K

-167.48%-305K

-15.34%160K

-366.07%-1.04M

719.59%1.2M

-Change in inventory

-33.75%-107K

358.06%560K

-2.38%616K

162.55%167K

-793.75%-143K

85.84%-80K

10.70%-217K

434.75%631K

6.97%-267K

-109.52%-16K

-Change in prepaid assets

-155.56%-115K

-21.10%172K

-243.75%-55K

118.82%186K

-30.08%86K

-273.08%-45K

519.23%218K

-155.17%-16K

191.40%85K

-33.87%123K

-Change in payables and accrued expense

516.22%308K

-273.61%-1.16M

-131.54%-170K

-1,920.51%-1.42M

144.70%506K

-106.26%-74K

509.20%667K

226.82%539K

-86.73%78K

-90.89%-1.13M

-Change in other current assets

60.38%85K

128.07%400K

12.75%115K

-62.37%105K

4.10%127K

102.75%53K

-5,800.00%-1.43M

142.32%102K

200.00%279K

40.23%122K

-Change in other current liabilities

-76.47%-60K

-127.46%-438K

-7.69%-126K

-12.50%-126K

-29.91%-152K

-101.75%-34K

2,898.25%1.6M

-146.80%-117K

-4.67%-112K

-14.71%-117K

Cash from discontinued investing activities

Operating cash flow

-32.43%-1.57M

37.92%-4.13M

74.03%-314K

78.51%-363K

-33.43%-2.27M

42.29%-1.19M

27.61%-6.65M

72.00%-1.21M

-15.05%-1.69M

14.49%-1.7M

Investing cash flow

Cash flow from continuing investing activities

8,315.38%1.07M

83.04%-19K

-2K

97.50%-2K

75.00%-2K

45.83%-13K

99.07%-112K

-370.59%-80K

-300.00%-8K

Net PPE purchase and sale

84.62%-2K

83.04%-19K

---2K

97.50%-2K

75.00%-2K

45.83%-13K

-115.38%-112K

--0

-370.59%-80K

-300.00%-8K

Net business purchase and sale

--1.07M

----

--0

----

Cash from discontinued investing activities

Investing cash flow

8,315.38%1.07M

83.04%-19K

---2K

97.50%-2K

75.00%-2K

45.83%-13K

99.07%-112K

--0

-370.59%-80K

-300.00%-8K

Financing cash flow

Cash flow from continuing financing activities

-597K

-58.77%1.91M

-100.86%-26K

-133.88%-577K

2.51M

-72.40%4.63M

-79.49%3.04M

677.63%1.7M

Net issuance payments of debt

---578K

1,553.33%1.53M

---704K

---577K

--2.81M

--0

-200.00%-105K

--0

Net preferred stock issuance

----

--0

----

-79.64%3.04M

----

Proceeds from stock option exercised by employees

----

-66.82%565K

--565K

----

--1.7M

--0

----

Net other financing activities

---19K

---181K

--113K

--0

----

Cash from discontinued financing activities

Financing cash flow

---597K

-58.77%1.91M

-100.86%-26K

-133.88%-577K

--2.51M

--0

-72.40%4.63M

-79.49%3.04M

677.63%1.7M

--0

Net cash flow

Beginning cash position

-38.32%3.61M

-26.73%5.85M

-1.79%3.95M

19.68%4.89M

-28.02%4.17M

-26.73%5.85M

-35.79%7.98M

-57.70%4.02M

-62.06%4.09M

-47.25%5.79M

Current changes in cash

19.52%-1.31M

-5.02%-2.24M

-118.73%-342K

-1,327.27%-942K

139.13%668K

25.71%-1.62M

52.05%-2.13M

219.82%1.83M

94.79%-66K

-697.66%-1.71M

End cash Position

-44.87%2.3M

-38.32%3.61M

-1.79%3.95M

19.68%4.89M

-28.02%4.17M

-26.73%5.85M

-57.70%4.02M

-62.06%4.09M

Free cash flow

-31.17%-1.57M

38.66%-4.15M

73.86%-316K

79.37%-365K

-32.92%-2.27M

42.34%-1.2M

26.81%-6.77M

72.05%-1.21M

-19.12%-1.77M

14.18%-1.71M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-32.43%-1.57M	37.92%-4.13M	74.03%-314K	78.51%-363K	-33.43%-2.27M	42.29%-1.19M	27.61%-6.65M	72.00%-1.21M	-15.05%-1.69M	14.49%-1.7M
Net income from continuing operations	-129.74%-3.09M	9.13%-9.64M	49.94%-4.11M	-1,191.91%-1.76M	-12.76%-2.43M	-1,111.71%-1.35M	-82.14%-10.61M	-5,093.67%-8.21M	94.06%-136K	-15.92%-2.16M
Operating gains losses	--606K	94.27%-312K	94.26%-56K	88.19%-285K	----	----	-18.34%-5.45M	78.85%-976K	---2.41M	--0
Depreciation and amortization	-7.69%12K	-57.97%203K	-59.35%50K	-57.14%51K	-25.83%89K	-89.26%13K	305.88%483K	41.38%123K	891.67%119K	990.91%120K
Other non cash items	--783K	45.63%1.98M	269.01%578K	-50.73%947K	----	----	--1.36M	---342K	--1.92M	--0
Change In working capital	-18.57%57K	40.71%750K	-58.66%537K	163.68%619K	-361.54%-476K	191.67%70K	1,502.63%533K	1,723.75%1.3M	-267.30%-972K	140.81%182K
-Change in receivables	-121.60%-54K	498.03%1.21M	-1.88%157K	264.93%1.71M	-174.88%-900K	139.56%250K	-167.48%-305K	-15.34%160K	-366.07%-1.04M	719.59%1.2M
-Change in inventory	-33.75%-107K	358.06%560K	-2.38%616K	162.55%167K	-793.75%-143K	85.84%-80K	10.70%-217K	434.75%631K	6.97%-267K	-109.52%-16K
-Change in prepaid assets	-155.56%-115K	-21.10%172K	-243.75%-55K	118.82%186K	-30.08%86K	-273.08%-45K	519.23%218K	-155.17%-16K	191.40%85K	-33.87%123K
-Change in payables and accrued expense	516.22%308K	-273.61%-1.16M	-131.54%-170K	-1,920.51%-1.42M	144.70%506K	-106.26%-74K	509.20%667K	226.82%539K	-86.73%78K	-90.89%-1.13M
-Change in other current assets	60.38%85K	128.07%400K	12.75%115K	-62.37%105K	4.10%127K	102.75%53K	-5,800.00%-1.43M	142.32%102K	200.00%279K	40.23%122K
-Change in other current liabilities	-76.47%-60K	-127.46%-438K	-7.69%-126K	-12.50%-126K	-29.91%-152K	-101.75%-34K	2,898.25%1.6M	-146.80%-117K	-4.67%-112K	-14.71%-117K
Cash from discontinued investing activities
Operating cash flow	-32.43%-1.57M	37.92%-4.13M	74.03%-314K	78.51%-363K	-33.43%-2.27M	42.29%-1.19M	27.61%-6.65M	72.00%-1.21M	-15.05%-1.69M	14.49%-1.7M
Investing cash flow
Cash flow from continuing investing activities	8,315.38%1.07M	83.04%-19K	-2K	97.50%-2K	75.00%-2K	45.83%-13K	99.07%-112K	0	-370.59%-80K	-300.00%-8K
Net PPE purchase and sale	84.62%-2K	83.04%-19K	---2K	97.50%-2K	75.00%-2K	45.83%-13K	-115.38%-112K	--0	-370.59%-80K	-300.00%-8K
Net business purchase and sale	--1.07M	----	----	----	----	--0	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	8,315.38%1.07M	83.04%-19K	---2K	97.50%-2K	75.00%-2K	45.83%-13K	99.07%-112K	--0	-370.59%-80K	-300.00%-8K
Financing cash flow
Cash flow from continuing financing activities	-597K	-58.77%1.91M	-100.86%-26K	-133.88%-577K	2.51M	0	-72.40%4.63M	-79.49%3.04M	677.63%1.7M	0
Net issuance payments of debt	---578K	1,553.33%1.53M	---704K	---577K	--2.81M	--0	-200.00%-105K	--0	--0	--0
Net preferred stock issuance	----	--0	----	----	----	----	-79.64%3.04M	----	----	----
Proceeds from stock option exercised by employees	----	-66.82%565K	--565K	----	----	----	--1.7M	--0	----	----
Net other financing activities	---19K	---181K	--113K	--0	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	---597K	-58.77%1.91M	-100.86%-26K	-133.88%-577K	--2.51M	--0	-72.40%4.63M	-79.49%3.04M	677.63%1.7M	--0
Net cash flow
Beginning cash position	-38.32%3.61M	-26.73%5.85M	-1.79%3.95M	19.68%4.89M	-28.02%4.17M	-26.73%5.85M	-35.79%7.98M	-57.70%4.02M	-62.06%4.09M	-47.25%5.79M
Current changes in cash	19.52%-1.31M	-5.02%-2.24M	-118.73%-342K	-1,327.27%-942K	139.13%668K	25.71%-1.62M	52.05%-2.13M	219.82%1.83M	94.79%-66K	-697.66%-1.71M
End cash Position	-44.87%2.3M	-38.32%3.61M	-38.32%3.61M	-1.79%3.95M	19.68%4.89M	-28.02%4.17M	-26.73%5.85M	-26.73%5.85M	-57.70%4.02M	-62.06%4.09M
Free cash flow	-31.17%-1.57M	38.66%-4.15M	73.86%-316K	79.37%-365K	-32.92%-2.27M	42.34%-1.2M	26.81%-6.77M	72.05%-1.21M	-19.12%-1.77M	14.18%-1.71M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall